TP53
Clinical trials for TP53 explained in plain language.
Never miss a new study
Get alerted when new TP53 trials appear
Sign up with your email to follow new studies for TP53, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug combo aims to keep aggressive uterine cancer at bay
Disease control Recruiting nowThis study is testing whether two drugs, abemaciclib and letrozole, can help control advanced or recurrent endometrial cancer after initial chemotherapy. The drugs are taken daily as maintenance therapy for up to two years to try to delay cancer progression. The trial will enroll…
Matched conditions: TP53
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for lymphoma patients with Tough-to-Treat genetic flaw
Disease control Recruiting nowThis study is testing a new combination of three drugs (glofitamab, a PD-1 inhibitor, and lenalidomide) for patients with an aggressive type of lymphoma that has come back or not responded to prior treatment and has a specific genetic change called TP53. The main goal is to see i…
Matched conditions: TP53
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC